Cannabis-based medicines

RPS Quick Reference Guide

From the 1st November 2018, the law changes widening access to cannabis-based products for medicinal use in humans in England, Scotland and Wales. (See The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018).

Cannabis-based product for medicinal use in humans’ can be available for medicinal use if:

  1. it meets the definition of ‘cannabis-based product for medicinal use in humans
  2. it is accessed through one of the three routes available.

Sections on this page

  • What is a 'cannabis-based product for human medicinal use'?
  • Supplying a 'cannabis-based product for human medicinal use'
  • Product check
  • Storage requirements
  • Clinical check 
  • Labelling requirements
  • Record keeping
  • Frequently asked questions
  • Reading and resources

Become a Royal Pharmaceutical Society member to view this content.

JOIN TODAY LOG IN